ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > BACE-1

BACE-1

概要

Name:Beta-secretase 1
Target Synonym:Beta-site amyloid precursor protein cleaving enzyme 1,KIAA1149,Asp 2,ASP2,Aspartyl protease 2,BACE,BACE1,Beta-Secretase 1,Membrane-Associated Aspartic Protease 2,Beta-Site APP-Cleaving Enzyme,Memapsin-2,Transmembrane Aspartic Proteinase Asp2,Beta-Site APP-Cleaving Enzyme 1,APP Beta-Secretase,EC 3.4.23.46,HSPC104,EC 3.4.23,Beta-Site APP Cleaving Enzyme 1,Beta-Site Amyloid Beta A4 Precursor Protein-Cleaving Enzyme,Beta-Secretase 1 Precursor Variant 1,EC:3.4.23.46
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 3 Clinical

製品リスト製品比較と製品注文

ACRO Quality

生物活性データの一部

BA1-H5213-MALS-HPLC
BACE-1 MALS images

The purity of Human BACE-1, Tag Free (Cat. No. BA1-H5213) is more than 90% and the molecular weight of this protein is around 55-65 kDa verified by SEC-MALS.

BA1-H5220-MALS-HPLC
BACE-1 MALS images

The purity of Human BACE-1, His Tag (Cat. No. BA1-H5220) is more than 95% and the molecular weight of this protein is around 55-65 kDa verified by SEC-MALS.

Synonym Name

BACE1,ASP2,BACE,FLJ90568,HSPC104,KIAA1149,Memapsin-2

Background

Beta-secretase 1 (BACE1) is also known as beta-site APP cleaving enzyme 1 (beta-site amyloid precursor protein cleaving enzyme 1), memapsin-2 (membrane-associated aspartic protease 2), and aspartyl protease 2 (ASP2), ¦Â-Secretase , and is a member of the peptidase A1 protein family, BACE1 is a type I

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
TAK-070 TAK-070 Phase 1 Clinical Takeda Alzheimer Disease Details
LY-2811376 LY-2811376 Eli Lilly And Company Details
Verubecestat MK-8931; SCH-900931; J1I0P6WT7T (UNII code) Merck Sharp & Dohme Corp Details
LY-3202626 LY-3202626 Phase 2 Clinical Eli Lilly And Company Alzheimer Disease Details
Elenbecestat E-2609; [14C]E2609 Phase 3 Clinical Eisai Co Ltd Alzheimer Disease Details
Lanabecestat AZD-3293; LY-3314814 Phase 3 Clinical Astrazeneca Pharmaceutical Co Ltd Renal Insufficiency; Alzheimer Disease; Hepatic Insufficiency Details

This web search service is supported by Google Inc.

totopphone